Schmid et al., "High plasma levels of gremlin-1 and
macrophage migration inhibitory factor, but not their ratio, indicate an increased risk for acute coronary syndrome in patients with type 2 diabetes mellitus," Clinical Cardiology, vol.
Koenig et al., "Association of systemic concentrations of
macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the cooperative health research in the region of Augsburg, survey 4 (KORA S4)," Diabetes Care, vol.
Carskadon et al., "
Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis," Clinical Cancer Research, vol.
Global Markets Direct's, '
Macrophage Migration Inhibitory Factor (Glycosylation-Inhibiting Factor or L-Dopachrome Isomerase or MIF or EC 5.3.2.1) - Pipeline Review, H1 2016', provides in depth analysis on
Macrophage Migration Inhibitory Factor (Glycosylation-Inhibiting Factor or L-Dopachrome Isomerase or MIF or EC 5.3.2.1) targeted pipeline therapeutics.
Hyperglycemia is a causal factor for increased levels of
macrophage migration inhibitory factor which plays a role in the development of cardiomyopathy occurring in patients with type 2 diabetes.
Macrophage migration inhibitory factor (MIF) is a chemokine that prevents the random migration of macrophages, stimulates their recruitment at sites of inflammation, and increases their adherence, motility, and phagocytosis [71].
Macrophage migration inhibitory factor and its relationship with obesity and diabetes.
(11.) Rahman SH, Menon KV, Holmfield JH, McMahon MJ, Guillou JP: Serum
macrophage migration inhibitory factor is an early marker of pancreatic necrosis in acute pancreatitis.
Macrophage migration inhibitory factor (MIF) activates macrophages and may therefore play a role in retaining these cells into the inflammatory sites [45].
The researchers whittled the field of potential biomarkers down to eight: prolactin, transthyretin, thrombospondin-1, E-selectin, C-C motif chemokine 5,
macrophage migration inhibitory factor, plasminogen activator inhibitor 1, and receptor tyrosine-protein kinase erbB-2.
Macrophage migration inhibitory factor (MIF) is a cytokine produced by lymphocytes and peripheral blood mononuclear cells.
A number of adipokines, including leptin, adiponectin, tumour necrosis factor alpha, IL-1beta (interleukin 1beta), IL-6, monocyte chemotactic protein-1,
macrophage migration inhibitory factor, nerve growth factor, vascular endothelial growth factor, plasminogen activator inhibitor 1 and haptoglobin, are linked to inflammation and the inflammatory response.
